PET and CT Scans to Evaluate Patients With Stage III or Stage IV Melanoma

Phase 2 Completed Memorial Sloan Kettering Cancer Center National Cancer Institute (NCI) · collab

Diagnostic

Summary

RATIONALE: Diagnostic procedures may improve the ability to detect metastatic melanoma and to determine the extent of disease. PURPOSE: Phase II trial to evaluate the effectiveness of PET and CT scans to detect metastatic disease in patients who have stage III or stage IV melanoma.

Timeline

Start: 1999-02
Primary completion: 2002-12
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Background	iodinated contrast dye	Diagnostic / imaging agent	—	Intravenous

PET and CT Scans to Evaluate Patients With Stage III or Stage IV Melanoma

Summary

Timeline

Drugs

Indications